Clinical Trial Results: Positive or negative data from Intellia Therapeutics' clinical trials heavily impacts investor confidence and stock value.

Regulatory Approvals: Decisions by regulatory bodies like the FDA regarding Intellia's therapies significantly influence market sentiment.

Competition: Advances by rival companies in gene editing or similar therapeutic areas can affect Intellia's perceived market share.

Partnerships: Collaborations or licensing agreements with other pharmaceutical companies often lead to stock price fluctuations.

Financial Performance: Intellia's cash position, research & development expenses, and revenue streams affect investor outlook.

Market Conditions: Broader economic trends and overall market sentiment in the biotechnology sector can influence NTLA's price.

Scientific Publications: Important publications highlighting the effectiveness or safety of Intellia's technology impact credibility.

Investor Sentiment: General investor mood and speculative trading activities can cause short-term price volatility.